Pneumonitis due to solids and liquids

J10_PNEUMONISOLLIQ

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J69 Hospital discharge: ICD-9 — 507 Cause of death: ICD-10 — J69 Cause of death: ICD-9 — 507 2 out of 7 registries used, show all original rules.	3268
4. Check minimum number of events None	3268
5. Include endpoints None	3268
6. Filter based on genotype QC (FinnGen only)	3268

Control definitions (FinnGen only)

Control exclude: J10_EXTERLUNG

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J60-J70
Name in latin: Pneumonitis ex inhalatione materiarum solidarum sive liquidarum

NAME	J10_PNEUMONISOLLIQ
CONTROL_EXCLUDE	J10_EXTERLUNG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J69
HD_ICD_9	507
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J69
COD_ICD_9	507
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pneumonitis due to solids and liquids based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41557	15557	25376
Only index persons	29612	11342	18270
Unadjusted period prevalence (%)
Whole population	0.61	0.45	0.71
Only index persons	0.59	0.42	0.70
Median age at first event (years)
Whole population	73.64	77.32	71.37
Only index persons	73.14	76.95	70.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3268	967	2301
Unadjusted period prevalence (%)	0.81	0.33	1.01
Median age at first event (years)	71.72	66.79	73.79

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2920: Matched controls
29197

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4503599627370496.0

323.0

2670

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.2

280.4

1082

2990

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.2

273.3

1544

6194

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.6

254.5

1124

3508

T36

ICD-10 Finland

Poisoning by systemic antibiotics

13.3

229.6

420

363

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

15.5

205.4

350

254

J69.8

ICD-10 Finland

Pneumonitis due to other solids and liquids

+∞

199.3

189

AA1AD

NOMESCO Finland

CT of head and brain

3.5

186.5

1190

4826

N05AH04

ATC

quetiapine; oral

4.2

168.2

765

2300

N03AG01

ATC

valproic acid; systemic, rectal

6.4

140.3

397

697

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.2

124.1

361

652

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.2

122.4

412

887

WX730

NOMESCO Finland

Conventional respirator

12.8

121.5

223

187

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

108.3

592

1992

JDB10

NOMESCO Finland

Percutaneous gastrostomy

13.7

106.3

189

147

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.8

105.4

387

908

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

5.1

104.4

354

762

N05AX08

ATC

risperidone; systemic

3.7

103.2

502

1532

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.5

100.8

277

460

N05AH03

ATC

olanzapine; systemic

5.3

91.6

301

622

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.4

89.1

500

1692

N06AB04

ATC

citalopram; systemic

2.6

86.6

768

3503

ZXD05

NOMESCO Finland

Urgent procedure

2.3

85.7

1107

6137

N05BA04

ATC

oxazepam; oral

2.5

84.2

869

4296

WX892

NOMESCO Finland

Monitored bed care

3.8

83.9

392

1142

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

11.5

83.9

161

147

WX872

NOMESCO Finland

Intensive care

4.7

82.5

301

694

R13

ICD-10 Finland

Dysphagia

4.1

81.8

352

953

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.1

80.8

190

250

N05BA01

ATC

diazepam; systemic, rectal

2.9

80.6

563

2208

5070A

ICD-9 Finland

Pneumonitis due to solids and liquids, Due to inhalation of food or vomitus

+∞

80.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.5

79.6

412

1303

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

79.4

557

2189

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.8

79.0

608

2532

N05AA02

ATC

levomepromazine; systemic

4.9

75.9

265

582

N06AX11

ATC

mirtazapine; oral

2.2

74.5

969

5304

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

74.0

1086

6272

N03AX14

ATC

levetiracetam; systemic

7.3

73.9

186

271

A06AD11

ATC

lactulose; oral

2.4

73.3

733

3519

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

71.0

451

1648

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

8.4

70.9

162

203

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.5

69.0

353

1100

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

68.3

967

5449

N03AX09

ATC

lamotrigine; oral

6.0

67.1

194

341

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

63.8

417

1546

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

7.2

63.7

160

232

N05CD07

ATC

temazepam; oral

2.5

62.9

593

2731

N07BB01

ATC

disulfiram; oral

4.9

62.6

215

462

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.5

60.7

128

140

R53

ICD-10 Finland

Malaise and fatigue

2.2

60.3

746

3915

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.0

60.1

383

1393

N05AX12

ATC

aripiprazole; systemic

7.0

59.8

153

228

N06AX16

ATC

venlafaxine; oral

3.0

59.6

380

1380

F10.20

ICD-10 Finland

Alcohol dependence currently independent

7.9

59.6

141

187

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

12.0

59.4

111

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

58.6

275

795

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

58.4

690

3540

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.4

57.8

220

525

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.4

57.8

143

203

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

56.9

275

814

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

56.9

712

3743

N05AF03

ATC

chlorprothixene; systemic

6.8

56.8

148

226

G41.9

ICD-10 Finland

Status epilepticus, unspecified

17.1

56.2

N03AF01

ATC

carbamazepine; oral, rectal

3.6

55.3

267

789

GBB00

NOMESCO Finland

Tracheostomy

9.5

54.7

115

125

TJD20

NOMESCO Finland

Change of gastrostomy tube

23.2

54.6

N05AH02

ATC

clozapine; systemic

9.2

54.5

117

132

F20.9

ICD-10 Finland

Schizophrenia, unspecified

7.5

53.7

131

182

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

53.6

376

1450

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.6

52.7

140

220

N04AA02

ATC

biperiden; systemic

7.7

52.6

126

170

N03AE01

ATC

clonazepam; systemic

3.7

52.5

244

698

J96.0

ICD-10 Finland

Acute respiratory failure

7.9

52.4

123

161

Z2446

NOMESCO Finland

Social worker

3.4

52.2

277

880

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

52.1

1315

8997

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.4

52.0

128

180

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.9

51.6

150

265

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

51.4

536

2572

J69

ICD-10 Finland

Pneumonitis due to solids and liquids

+∞

51.2

C03CA01

ATC

furosemide; systemic

1.8

51.1

1227

8237

A28

ICPC

Limited function/disability NOS

2.1

50.8

653

3449

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.3

50.5

162

322

N05CF01

ATC

zopiclone; oral

1.9

49.8

1060

6807

L28

ICPC

Limited function/disability (L)

2.2

49.6

592

3020

R4130

NOMESCO Finland

Speech therapy

6.0

49.5

141

243

Z3226

NOMESCO Finland

Physiotherapist

2.2

48.8

590

3025

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

48.8

553

2752

J01MA12

ATC

levofloxacin; systemic

2.1

48.3

695

3839

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

7.7

48.1

115

155

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

48.0

243

744

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

12.8

47.2

WX882

NOMESCO Finland

High dependency care

4.8

47.2

164

356

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.5

47.0

114

157

N05AB03

ATC

perphenazine; systemic, rectal

4.8

46.7

164

360

N05AN01

ATC

lithium; oral

6.9

46.7

120

180

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

46.2

239

744

F05.9

ICD-10 Finland

Delirium, unspecified

5.0

44.8

151

317

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.2

44.3

110

157

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.8

44.0

114

173

F10.24

ICD-10 Finland

Alcohol depence active use

8.5

43.8

119

G72.8

ICD-10 Finland

Other specified myopathies

6.4

43.8

119

193

J01MA14

ATC

moxifloxacin; systemic

2.6

43.4

340

1393

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

7.7

43.3

103

138

P15

ICPC

Chronic alcohol abuse

5.5

42.9

131

246

R50.9

ICD-10 Finland

Fever, unspecified

2.2

42.4

477

2352

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.5

42.0

D21

ICPC

Swallowing problem

7.7

41.8

132

B18.2

ICD-10 Finland

Chronic viral hepatitis C

12.8

41.8

R11

ICD-10 Finland

Nausea and vomiting

2.8

41.7

284

1066

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

41.5

542

2851

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

41.0

488

2464

R40.2

ICD-10 Finland

Coma, unspecified

8.2

40.0

114

N06AB10

ATC

escitalopram; oral

2.2

39.8

484

2464

N05AD01

ATC

haloperidol; systemic

3.6

39.5

189

552

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

8.4

39.4

107

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.4

39.3

202

624

K90

ICPC

Stroke/cerebrovascular accident

3.8

39.2

173

472

N03AF02

ATC

oxcarbazepine; oral

4.2

39.1

154

379

N06AB06

ATC

sertraline; oral

2.7

39.1

289

1142

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.0

38.5

127

261

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

11.5

38.2

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.6

38.1

180

520

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

10.5

38.0

WX704

NOMESCO Finland

Intubation

3.0

37.9

241

863

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

10.1

37.7

J69.1

ICD-10 Finland

Pneumonitis due to oils and essences

+∞

37.6

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

36.6

190

592

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

36.3

542

2993

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

36.3

497

2653

R4110

NOMESCO Finland

Physiotherapy

1.8

36.1

733

4527

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

36.0

1228

8869

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

9.3

36.0

N87

ICPC

Parkinsonism

6.6

35.6

147

N05AA01

ATC

chlorpromazine; systemic, rectal

7.2

35.2

124

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

34.8

177

542

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

34.6

541

3037

K92.0

ICD-10 Finland

Haematemesis

3.9

34.4

146

385

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

17.2

34.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.2

33.3

153

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

7.7

33.0

104

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.5

33.0

162

483

Z3231

NOMESCO Finland

Registered nurse

1.7

32.9

797

5177

SPAT1254

SPAT

Administration of medicine

2.0

32.7

504

2808

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

7.4

32.7

109

N05BA02

ATC

chlordiazepoxide; systemic

4.6

32.7

118

267

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

32.7

257

1049

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.0

32.7

198

688

G20

ICD-10 Finland

Parkinson disease

3.3

32.5

171

538

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.5

32.3

118

270

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.1

32.3

129

322

Z2445

NOMESCO Finland

Psychologist

4.2

31.9

127

316

F60.9

ICD-10 Finland

Personality disorder, unspecified

10.7

31.9

N05AC02

ATC

thioridazine; oral

5.6

31.9

174

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

31.8

414

2154

N03AX18

ATC

lacosamide; systemic

12.6

31.8

N06AB03

ATC

fluoxetine; oral

2.3

31.7

319

1479

A02BC02

ATC

pantoprazole; systemic

1.6

30.9

1698

13666

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

30.8

858

5787

S01.0

ICD-10 Finland

Open wound of scalp

2.4

30.8

291

1310

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

30.6

186

647

N02AA05

ATC

oxycodone; systemic

1.9

30.5

513

2946

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.1

29.8

173

584

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

29.7

247

1036

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

9.6

29.6

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

29.4

234

961

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.3

29.0

151

472

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

28.8

503

2922

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

28.7

706

4577

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

10.5

28.7

F61.0

ICD-10 Finland

Mixed personality disorders

7.9

28.7

N05AF05

ATC

zuclopenthixol; systemic

8.1

28.6

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

28.4

320

1559

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

26.3

28.4

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

28.3

253

1103

XA800

NOMESCO Finland

Neuropsychological investigation

3.6

28.2

130

369

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

9.5

28.1

A04

ICPC

Weakness/tiredness general

2.0

28.0

392

2092

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

7.3

28.0

N03AX16

ATC

pregabalin; oral

1.8

28.0

604

3755

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.6

27.9

214

858

R47.1

ICD-10 Finland

Dysarthria and anarthria

6.9

27.8

103

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.2

27.8

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.4

27.7

162

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

27.7

443

2490

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

27.5

222

917

S06.0

ICD-10 Finland

Concussion

2.1

27.5

319

1577

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

27.4

476

2757

V03AA01

ATC

4.8

27.2

195

P16

ICPC

Acute alcohol abuse

6.1

27.2

125

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.6

27.2

129

375

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

11.8

27.1

Z72.2

ICD-10 Finland

Drug use

18.9

27.0

SPAT1229

SPAT

Assessment of need for aid

2.2

26.8

289

1381

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.2

26.6

147

480

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

19.3

26.5

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

7.3

26.5

N30.0

ICD-10 Finland

Acute cystitis

2.0

26.5

357

1878

P72

ICPC

Schizophrenia

5.9

26.4

130

P99

ICPC

Psychological disorders other

5.0

26.3

176

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.3

26.3

264

1222

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.4

26.1

152

SPAT1240

SPAT

Therapeutic discussion

2.5

25.7

219

930

W19

ICD-10 Finland

Unspecified fall

2.1

25.4

310

1564

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

25.1

154

538

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.3

25.0

108

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.7

24.9

176

674

C07AA05

ATC

propranolol; systemic

1.9

24.8

422

2418

N06AX03

ATC

mianserin; oral

2.8

24.8

168

628

N05BE01

ATC

buspirone; oral

3.9

24.8

104

273

Z2221

NOMESCO Finland

Medical doctor

1.6

24.5

713

4810

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

24.4

214

921

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

8.1

24.4

G40

ICD-10 Finland

Epilepsy

8.5

24.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

24.3

240

1100

N06AX21

ATC

duloxetine; oral

2.2

24.1

251

1179

R4120

NOMESCO Finland

Occupational therapy

2.6

24.1

188

763

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

6.9

24.0

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

24.0

167

635

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.4

23.9

117

349

N06AA09

ATC

amitriptyline; systemic

2.1

23.8

279

1383

SPAT1265

SPAT

Breathalyser

8.4

23.6

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

23.4

592

3839

J01DB01

ATC

cefalexin; oral

1.5

23.4

2061

17861

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.9

23.3

160

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

23.3

177

708

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.0

23.1

108

J01DA01

ATC

[U] cefalexin; systemic

1.5

22.9

1634

13498

GD1AD

NOMESCO Finland

Thorax CT examination

2.8

22.9

149

544

N03AB02

ATC

phenytoin; systemic

4.7

22.6

170

N18

ICPC

Paralysis/weakness

4.0

22.4

237

183

Kela drug reimbursment

Lamotrigin and topiramate

8.2

22.4

N06AX12

ATC

bupropion; oral

3.1

22.4

128

428

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.7

22.4

157

599

P29

ICPC

Psychological sympt/compl other

3.1

22.2

127

424

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

16.9

22.2

K56.0

ICD-10 Finland

Paralytic ileus

5.7

22.0

115

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

22.0

943

6969

F03

ICD-10 Finland

Unspecified dementia

2.2

21.9

229

1076

ZY000

NOMESCO Finland

Hospital inpatient

7.0

21.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

21.9

146

541

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.3

21.8

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

18.5

21.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

21.7

819

5873

M03BX01

ATC

baclofen; systemic

4.8

21.6

156

R33

ICD-10 Finland

Retention of urine

1.9

21.6

349

1958

T51.0

ICD-10 Finland

Toxic effect: Ethanol

15.4

21.5

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

43.7

21.4

Z72.1

ICD-10 Finland

Alcohol use

6.3

21.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

21.3

418

2501

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.3

21.3

128

R81

ICPC

Pneumonia

3.1

21.3

121

402

SPAT1216

SPAT

Assessment of functional ability

1.7

21.3

480

3000

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

3.7

21.3

259

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

20.9

21.2

S72.0

ICD-10 Finland

Fracture of neck of femur

2.4

21.2

188

817

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.0

21.0

217

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.0

21.0

139

N99

ICPC

Neurological disease other

5.6

21.0

110

R1260

NOMESCO Finland

Evaluation of communicative skills

4.1

20.9

203

WX722

NOMESCO Finland

PEEP

2.6

20.9

162

655

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.7

20.9

144

544

C07AB07

ATC

bisoprolol; oral

1.5

20.9

1399

11319

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

6.5

20.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

20.8

125

433

SPAT1234

SPAT

Support of social functional capacity

2.3

20.8

201

910

N19

ICPC

Speech disorder

5.3

20.7

124

ZXE00

NOMESCO Finland

One hour or less

1.5

20.7

989

7455

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.4

20.7

116

TAB00

NOMESCO Finland

Lumbar puncture

3.1

20.7

114

373

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

20.5

150

587

E86

ICD-10 Finland

Volume depletion

3.0

20.5

119

403

T68

ICD-10 Finland

Hypothermia

8.6

20.4

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

15.1

20.2

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.7

20.2

250

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.1

20.1

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

10.4

20.1

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

17.4

20.0

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.8

19.8

134

501

N05BA09

ATC

clobazam; oral

15.4

19.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

19.6

398

2405

AAF00

NOMESCO Finland

Ventriculostomy

8.7

19.6

AA400

NOMESCO Finland

Electroconvulsive therapy

9.4

19.6

N05BA12

ATC

alprazolam; oral

2.0

19.6

263

1377

ZY010

NOMESCO Finland

Hospital outpatient

3.0

19.2

115

396

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

16.8

19.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

19.1

169

732

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

9.9

19.1

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

18.3

19.1

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

18.9

274

1475

JN4BD

NOMESCO Finland

Extensive body CT

1.9

18.9

318

1804

JAH00

NOMESCO Finland

Laparotomy

3.1

18.8

108

363

S06.3

ICD-10 Finland

Focal brain injury

4.5

18.8

152

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

15.9

18.8

P76

ICPC

Depressive disorder

2.9

18.7

116

411

SPAT1255

SPAT

Intravenous administration of medicine

2.2

18.7

203

971

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.7

18.7

225

OAB43

SPAT

0.3

18.7

1269

A02BC05

ATC

esomeprazole; systemic

1.5

18.7

954

7254

ZX120

NOMESCO Finland

Intravenous

2.0

18.7

260

1379

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.4

18.6

158

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

18.8

18.6

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

9.4

18.6

P19

ICPC

Drug abuse

7.9

18.5

R55

ICD-10 Finland

Syncope and collapse

1.8

18.5

353

2089

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.0

18.5

247

1290

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

18.5

360

2147

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

18.4

133

517

N06AX05

ATC

trazodone; oral

3.9

18.3

194

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3.5

18.3

250

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

18.3

421

2640

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

17.7

18.2

SPAT1262

SPAT

Handing over of treatment supplies

1.6

18.1

508

3360

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.0

18.1

118

J96.1

ICD-10 Finland

Chronic respiratory failure

3.0

18.0

107

369

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.8

18.0

T75.1

ICD-10 Finland

Drowning and nonfatal submersion

52.8

18.0

JN4AD

NOMESCO Finland

Body CT examination

2.0

17.9

225

1145

P18

ICPC

Medication abuse

9.6

17.9

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

17.8

227

1162

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.9

17.7

195

Z43.1

ICD-10 Finland

Attention to gastrostomy

20.2

17.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

17.7

117

432

5CM18

NOMESCO Finland

8.9

17.6

N88

ICPC

Epilepsy

9.8

17.6

K59.0

ICD-10 Finland

Constipation

2.2

17.6

190

907

E87.6

ICD-10 Finland

Hypokalaemia

3.0

17.6

104

358

X58

ICD-10 Finland

Exposure to other specified factors

1.8

17.6

313

1812

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.2

17.4

164

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

10.8

17.4

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.3

17.4

102

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

9.1

17.4

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

17.3

263

1441

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

42.2

17.3

N28

ICPC

Limited function/disability (N)

4.0

17.3

180

T74.1

ICD-10 Finland

Physical abuse

6.2

17.3

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1633

7765

3.20

230.82

6.6

4.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

311

547

6.18

171.13

2.6

umol/l

31.5

35.7

1.21

271

449

(3012095) Magnesium [Moles/volume] in Serum or Plasma

929

3970

2.87

146.45

4.6

3.1

mmol/l

0.8

5.21

856

3671

(3028707) Methadone [Presence] in Urine by Screen method

186

221

8.86

145.50

5.7

3.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

829

3434

2.89

137.46

5.9

5.7

mmol/l

1.0

4.95

758

3157

(3009466) Valproate [Moles/volume] in Serum or Plasma

216

340

6.73

132.09

5.9

4.7

umol/l

353.2

349.9

0.11

190

295

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

538

1881

3.23

118.93

1.9

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

138

166

8.64

106.65

1.9

1.4

promille

1.2

1.1

0.12

105

129

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

920

4519

2.44

104.27

2.5

1.8

—

(3003396) Base excess in Arterial blood by calculation

714

3119

2.65

103.69

12.1

6.7

mmol/l

2.0

1.0

5.60

569

2367

(3020779) Urea [Moles/volume] in Serum or Plasma

610

2507

2.76

99.60

6.7

6.8

mmol/l

9.0

11.4

10.99

571

2360

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

379

1202

3.44

97.24

2.6

1.9

ug/l

2.7

2.6

0.05

328

1035

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

475

1727

3.05

97.07

5.7

3.7

mmol/l

2.5

1.8

3.45

377

1238

(3009343) pH of Capillary blood

485

1791

3.01

96.39

5.8

3.8

7.4

0.04

208

(1001926) Buprenorphine [Presence] in Urine by Screen method

197

386

5.37

95.75

5.1

2.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

487

1815

2.98

95.14

5.9

3.7

kpa

5.3

5.1

3.86

449

1662

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

697

3128

2.56

94.92

12.3

6.7

kpa

5.3

5.1

5.55

644

2949

(3027801) Oxygen [Partial pressure] in Arterial blood

695

3128

2.55

93.99

12.3

6.7

kpa

10.9

11.7

4.40

643

2949

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

321

933

3.71

93.99

3.0

2.2

ug/l

455.8

593.6

0.53

299

875

(4198724)

13.99

93.09

4.2

1.7

—

(3016879) Cocaine [Presence] in Urine

209

450

4.89

91.08

5.5

2.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1277

7532

2.14

90.80

3.8

2.1

u/l

298.3

241.4

1.18

1219

7011

(3011288) Drugs identified in Urine by Screen method

174

324

5.62

89.37

7.1

3.1

—

(3000764) Benzodiazepines [Presence] in Urine

211

480

4.63

85.95

5.7

2.3

—

(3027008) Opiates [Presence] in Urine

210

486

4.55

83.70

5.7

2.3

—

(3028300) Cannabinoids [Presence] in Urine

209

487

4.52

82.58

5.9

2.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

437

1654

2.90

82.39

1.9

1.5

—

(3016502) Oxygen saturation in Arterial blood

619

2819

2.48

80.49

13.3

7.0

94.0

95.2

3.79

587

2695

(3014111) Lactate [Moles/volume] in Serum or Plasma

553

2398

2.57

79.74

10.1

6.3

mmol/l

1.5

1.4

0.71

518

2281

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.57

72.64

1.8

2.0

umol/l

82.1

100.3

0.24

(3027944) Amphetamines [Presence] in Urine

195

476

4.29

72.47

5.8

2.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

578

2677

2.41

71.73

5.1

3.6

kpa

6.0

5.8

3.09

548

2584

(3002032) Base excess in Venous blood by calculation

577

2674

2.41

71.49

5.1

3.6

mmol/l

2.6

1.9

4.07

487

2081

(3019060) Gas panel - Arterial blood

447

1849

2.64

70.46

9.6

4.5

—

(3012544) pH of Venous blood

588

2765

2.37

70.41

5.2

3.7

7.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1198

7445

1.96

69.21

3.5

2.5

u/l

57.4

59.1

0.33

1126

6861

(3024354) Oxygen [Partial pressure] in Venous blood

499

2199

2.50

68.86

4.7

3.1

kpa

4.7

4.4

2.43

468

2118

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1614

11129

1.89

67.48

11.6

6.0

mmol/l

1.2

8.14

1472

9996

(3022313) Gas panel - Capillary blood

349

1309

2.87

66.32

6.2

3.9

—

(3023419) Bacteria identified in Sputum by Culture

149

318

4.86

65.44

2.5

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

626

3124

2.24

64.69

2.4

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

625

3118

2.24

64.63

2.4

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

492

2216

2.44

64.48

3.0

2.1

g/l

0.2

6.66

432

2037

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1741

12446

1.85

63.50

8.4

5.9

umol/l

11.4

12.7

2.92

1667

11767

(3026008) Bacteria identified in Urine by Culture

1165

7408

1.89

61.02

4.3

3.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1547

10755

1.83

60.84

6.8

4.7

g/l

31.7

34.7

54.26

1397

9905

(3002173) Hemoglobin [Mass/volume] in Arterial blood

524

2520

2.29

58.74

15.1

7.5

g/l

117.2

121.2

4.12

502

2426

(3008152) Bicarbonate [Moles/volume] in Arterial blood

406

1744

2.52

58.66

14.0

6.6

mmol/l

25.4

24.3

5.64

377

1631

(3032080) INR in Blood by Coagulation assay

1539

10762

1.81

58.65

12.7

11.2

inr

1.3

1.4

1.05

422

2983

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

292

1079

2.87

56.78

6.8

4.2

mmol/l

25.4

24.7

2.86

269

989

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1695

12311

1.78

55.83

11.3

6.7

mmol/l

1.2

4.95

1394

10276

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

106

194

5.61

55.35

1.8

1.5

—

(1616796) Gas panel - Central venous blood

205

628

3.42

54.84

4.9

3.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

917

5576

1.90

53.85

2.2

1.8

nmol/l

1209.9

1166.2

0.66

690

4158

(3000991) Gas panel - Venous blood

477

2292

2.27

53.23

12.2

7.4

—

(3042936) Bacteria identified in Isolate by Culture

640

3483

2.04

51.71

2.5

2.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1092

7107

1.81

51.02

4.6

3.1

u/l

40.8

38.9

0.24

1004

6728

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

360

1567

2.46

50.22

10.5

7.1

mmol/l

25.5

24.7

2.79

354

1556

(3013826) Glucose [Moles/volume] in Serum or Plasma

1893

14447

1.74

50.12

10.0

4.9

mmol/l

7.2

6.9

4.45

1811

13595

(3007853) Bacteria identified in Skin by Aerobe culture

542

2832

2.10

48.64

2.2

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1409

9988

1.72

48.08

6.2

4.2

ng/l

48.7

80.1

0.99

1183

7571

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

179

553

3.37

47.19

1.6

—

(3019069) Monocytes/100 leukocytes in Blood

1485

10718

1.71

47.14

8.1

6.0

8.5

8.9

4.49

1394

9940

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

233

842

2.90

47.03

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

185

586

3.29

46.85

1.6

—

(3010421) pH of Blood

211

727

3.03

46.36

6.8

4.6

7.4

0.03

178

616

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

15.56

46.02

1.1

1.3

mmol/l

—

(3006504) Eosinophils/100 leukocytes in Blood

1474

10671

1.69

45.84

7.6

5.8

2.3

2.9

18.11

1382

9859

(42870588) Differential panel, method unspecified - Blood

1159

7862

1.73

45.79

7.0

5.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

1500

10945

1.68

45.02

7.9

5.9

21.8

26.2

39.51

1396

10090

(3022096) Basophils/100 leukocytes in Blood

1438

10378

1.69

44.98

7.4

5.8

0.5

0.6

18.39

1352

9602

(3006315) Basophils [#/volume] in Blood

1540

11356

1.67

44.07

7.4

5.5

e9/l

0.0

1.94

1342

9682

(3018677) aPTT in Platelet poor plasma by Coagulation assay

694

4080

1.89

43.99

2.2

2.0

30.3

0.05

665

3948

(3018010) Neutrophils/100 leukocytes in Blood

1473

10774

1.67

43.21

7.6

5.7

63.4

58.5

37.54

1380

9992

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

400

3.67

43.11

1.6

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

321

1420

2.40

42.98

13.5

8.5

mmol/l

24.9

24.2

2.13

298

1298

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

452

2314

2.11

42.42

3.2

1.8

1.7

1.5

3.44

388

2001

(3026782) Osmolality of Urine

835

5257

1.79

42.15

3.8

2.9

mosm/kgh2o

532.1

561.9

3.95

748

4488

(3044640) Blood type and Crossmatch panel - Blood

1106

7539

1.71

42.11

3.4

2.6

—

(3001604) Monocytes [#/volume] in Blood

1523

11290

1.65

42.00

7.4

5.5

e9/l

0.7

0.6

7.41

1333

9621

(3019198) Lymphocytes [#/volume] in Blood

1554

11595

1.65

41.65

7.6

5.6

e9/l

1.7

1.9

2.77

1362

10062

(3012501) Base excess in Blood by calculation

184

625

3.06

41.40

7.0

4.9

mmol/l

3.2

2.7

1.15

151

404

(3013290) Carbon dioxide [Partial pressure] in Blood

184

626

3.06

41.29

7.0

4.9

kpa

5.1

5.0

1.22

178

616

(3027315) Oxygen [Partial pressure] in Blood

184

627

3.05

41.17

7.0

4.9

kpa

8.0

8.3

2.33

178

616

(3013115) Eosinophils [#/volume] in Blood

1560

11709

1.64

40.39

8.4

5.7

e9/l

0.2

5.75

1373

10152

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

253

1035

2.57

40.02

3.5

2.6

u/ml

0.4

0.3

0.38

143

588

(3014576) Chloride [Moles/volume] in Serum or Plasma

587

3374

1.90

39.44

12.8

6.4

mmol/l

104.0

104.3

0.69

567

3275

(3028626) Oxygen [Partial pressure] in Capillary blood

198

721

2.86

39.32

5.9

3.3

kpa

7.7

7.9

1.15

182

668

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

297

1319

2.38

39.32

4.9

3.7

mmol/l

24.8

24.0

3.59

272

1179

(3015235) Bicarbonate [Moles/volume] in Capillary blood

207

776

2.78

38.93

4.4

3.2

mmol/l

25.7

24.8

1.75

188

674

(3003181) Sodium [Moles/volume] in Urine

146

452

3.33

38.33

1.8

1.3

mmol/l

65.6

63.6

0.18

115

359

(3033658) Prothrombin time (PT) actual/Normal

908

5999

1.71

38.02

6.1

4.0

82.0

83.5

0.98

875

5836

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1001

6796

1.68

37.83

2.7

2.2

mg/l

3.4

3.1

2.43

836

5718

(40767503) Oxygen content in Capillary blood by calculation

170

586

3.01

37.26

3.6

2.4

15.6

15.8

0.20

296

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

137

416

3.39

37.09

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

116

316

3.77

36.98

1.5

1.4

—

(3042517) Benzodiazepines panel - Urine

22.68

36.74

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

359

3.55

36.13

1.5

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

346

1697

2.16

36.01

4.8

3.2

g/l

124.1

127.6

2.05

330

1659

(3031040) Bacteria [#/volume] in Urine by Automated count

1941

15622

1.60

35.79

6.7

4.8

e6/l

1478.2

1906.4

0.17

297

(3027273) Bicarbonate [Moles/volume] in Venous blood

305

1437

2.24

35.05

5.0

3.5

mmol/l

25.6

25.0

2.70

291

1390

(3013650) Neutrophils [#/volume] in Blood by Automated count

1679

13153

1.57

34.06

12.9

8.3

e9/l

5.1

4.3

23.19

1483

11379

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

6.68

34.01

3.5

2.8

umol/l

32.5

30.8

0.17

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

321

3.61

33.89

1.6

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

479

2708

1.90

33.42

3.4

2.7

umol/l

9.5

9.7

0.08

401

2363

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.15

32.21

2.0

1.6

iu/ml

1565878.6

2090600.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

113

342

3.39

30.77

1.7

1.6

—

(3021901) Oxygen saturation in Capillary blood

157

577

2.81

30.62

3.6

2.8

—

(3044290) Cell count panel - Cerebral spinal fluid

125

405

3.17

30.47

1.8

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

215

925

2.42

30.42

3.0

2.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

225

988

2.37

30.42

8.5

3.7

mmol/l

1.7

1.4

2.01

217

971

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

134

454

3.03

30.27

1.4

1.3

mmol/l

4.2

3.8

2.16

126

418

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

334

1723

2.05

30.24

2.1

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

114

355

3.29

29.67

6.7

6.1

mg/l

11.3

12.0

0.90

104

326

(3018418) pH of Serum or Plasma

1008

7205

1.58

29.38

4.8

3.9

7.4

1.48

239

1399

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

271

1310

2.17

29.09

5.8

4.0

52.7

47.8

2.43

265

1297

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

321

1659

2.04

28.88

17.2

8.4

0.7

0.31

315

1646

(3036481) Cortisol [Moles/volume] in Serum or Plasma

356

1911

1.97

28.77

2.1

nmol/l

375.7

373.1

0.06

316

1734

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

142

512

2.85

28.70

1.6

1.3

mg/l

735.1

545.9

0.46

130

479

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

232

1062

2.28

28.46

2.3

1.9

—

(3017509) Phencyclidine [Presence] in Urine

17.81

28.16

3.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1822

21409

0.66

27.93

4.5

mmol/l

4.2

4.4

18.81

1618

19527

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

100

5.47

27.88

2.1

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

214

3.90

27.82

1.4

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

245

1158

2.21

27.80

2.4

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1886

21988

0.66

27.55

4.8

5.0

mmol/l

2.4

2.6

18.74

1646

19943

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

234

3.75

27.51

1.4

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

318

1667

2.01

27.46

17.2

8.2

1.5

1.3

1.36

312

1656

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

280

1415

2.07

26.72

17.8

9.4

—

(3002582) Erythrocytes [#/volume] in Urine

1063

7823

1.53

26.61

4.4

3.5

e6/l

56.7

118.3

1.89

884

6198

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1808

21190

0.67

26.40

4.5

4.4

mmol/l

1.3

1.4

10.64

1591

19172

(3027945) Reticulocytes/100 erythrocytes in Blood

536

3353

1.72

26.21

2.3

2.4

1.9

1.8

1.26

450

2936

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

160

644

2.56

26.09

1.7

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

160

644

2.56

26.09

1.7

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

311

1647

1.98

26.05

18.0

8.5

92.4

93.8

3.65

311

1639

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

6.68

25.93

2.2

2.3

nmol/l

164.4

134.8

0.71

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

449

2687

1.78

25.64

6.0

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

614

4022

1.65

25.12

24.2

29.6

inr

1.5

0.08

560

(3047181) Lactate [Moles/volume] in Blood

188

831

2.34

25.00

12.6

6.0

mmol/l

1.3

1.4

0.30

153

729

(3022948) Iron [Moles/volume] in Serum or Plasma

626

4130

1.64

24.87

2.7

2.5

umol/l

10.2

12.3

12.50

552

3795

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

152

4.27

24.67

1.9

1.2

mmol/l

2.4

2.1

0.84

139

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

4.66

24.52

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

439

6879

0.58

24.09

3.6

3.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

4.84

23.86

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

273

3.32

23.77

1.8

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

176

3.92

23.37

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

584

3840

1.63

23.37

2.7

2.5

g/l

2.2

2.3

1.67

516

3531

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

424

2568

1.75

23.09

2.9

2.4

ug/l

8.9

7.1

0.37

334

2188

(3019977) pH of Arterial blood

160

4.06

23.07

3.8

2.6

7.4

0.52

(3006184) Hemoglobin [Mass/volume] in Capillary blood

148

609

2.50

23.05

2.7

2.2

g/l

127.6

127.2

0.06

117

448

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

17.37

22.91

5.7

9.8

—

(3052851) Hemolysis interference index of Serum or Plasma

171

754

2.34

22.87

4.6

3.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

5.06

22.79

6.6

7.2

mmol/l

26.1

24.8

0.83

(3000850) Epithelial cells [#/volume] in Urine

781

5526

1.54

22.78

3.7

2.7

e6/l

5.6

4.4

2.00

723

4886

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

555

3626

1.64

22.73

2.8

2.6

19.0

22.2

6.91

456

3079

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

4.96

22.27

2.2

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

226

1128

2.08

22.24

10.9

5.1

1.7

1.6

0.43

203

1059

(3043409) Potassium [Moles/volume] in Arterial blood

181

828

2.26

22.21

9.7

3.9

mmol/l

3.9

0.28

158

757

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

363

2132

1.79

21.93

3.3

2.4

u/l

31.0

60.1

0.71

312

1820

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

797

5733

1.52

21.32

3.3

2.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

13.41

21.09

1.1

—

(3014271) Vancomycin [Susceptibility]

162

3.88

21.06

4.6

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

6.31

21.00

1.1

—

(3008295) Osmolality of Serum or Plasma

259

3.22

20.92

1.3

mosm/kgh2o

281.7

279.0

0.35

186

(3037467) Urinalysis macro (dipstick) panel - Urine

1887

16012

1.42

20.74

5.8

4.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

336

2.88

19.95

11.4

7.6

mmol/l

7.3

7.7

0.82

278

(3007930) Methemoglobin/Hemoglobin.total in Blood

217

1112

2.02

19.87

11.3

5.2

0.9

1.25

195

1044

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1077

8318

1.44

19.80

3.6

3.2

ng/l

2329.1

2042.8

0.86

930

7179

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.77

19.76

1.2

1.1

—

(3018095) Leukocytes [#/volume] in Urine

1127

8791

1.43

19.57

5.1

3.9

e6/l

85.0

118.7

1.21

908

6575

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2079

18040

1.42

19.53

10.3

7.3

u/l

87.4

81.7

3.97

1956

16849

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

6.02

19.49

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

144

3.94

19.47

3.1

2.4

—

(3036489) Thrombin time

173

822

2.17

19.35

2.1

2.0

21.8

21.6

0.12

155

742

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1337

10767

1.41

19.31

5.5

4.3

—

(3016018) Differential panel - Cerebral spinal fluid

201

3.43

19.30

1.9

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

211

3.37

19.27

1.7

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

132

4.06

19.24

1.7

1.5

—

(44790047)

257

3.13

19.22

1.6

1.5

—

(44790048)

257

3.13

19.22

1.6

1.5

—

(44806118)

257

3.13

19.22

1.6

1.5

—

(44790049)

257

3.13

19.22

1.6

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.59

19.13

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

715

5129

1.50

19.09

5.0

4.1

ng/l

256.6

651.7

1.41

587

4369

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

114

455

2.56

18.97

1.4

e6/l

41.6

27.8

0.17

359

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

114

455

2.56

18.97

1.5

e6/l

528.3

1082.6

0.54

372

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

145

646

2.30

18.96

2.7

2.4

g/l

4.0

3.6

1.33

138

611

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

134

4.00

18.86

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

133

577

2.36

18.49

1.7

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1790

20512

0.72

18.48

4.3

4.0

mmol/l

1.4

1.3

2.01

1588

18413

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

159

3.70

18.44

1.6

1.5

—

(40758558) Short blood count panel - Blood

783

5760

1.47

18.35

9.9

6.2

—

(3020891) Body temperature

211

1102

1.98

18.30

11.9

4.5

—

(3030467) Casts [#/volume] in Urine by Automated count

926

7042

1.44

18.19

4.3

3.3

e6/l

0.7

0.5

1.57

763

5478

(44816559) Phosphatidylethanol [Mass/volume] in Blood

355

2.73

18.03

2.0

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1281

10329

1.40

17.98

2.4

2.1

pmol/l

90.4

91.7

0.39

721

5605

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

158

748

2.17

17.84

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1653

13933

1.38

17.56

5.6

3.1

u/l

72.5

55.8

4.54

1540

12786

(3042631) Mycobacterium sp identified in Specimen

368

2.66

17.35

3.1

2.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

216

3.19

17.24

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

216

3.19

17.24

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

216

3.19

17.24

1.3

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

8.51

17.13

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1039

8136

1.41

17.10

3.6

3.2

mmol/l

2.3

6.27

855

6952

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1425

0.27

17.10

1.5

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

11.31

17.10

1.1

—

(3051651) Icteric interference index of Serum or Plasma

144

3.72

17.08

4.3

3.7

—

(3039000) Anion gap in Blood

131

587

2.28

16.92

16.0

6.9

mmol/l

10.5

11.5

2.28

112

524

(3018572) Chloride [Moles/volume] in Blood

131

588

2.28

16.86

16.0

6.9

mmol/l

105.0

105.3

0.19

112

525

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.85

16.83

1.6

1.4

—

(3024928) Oxygen saturation in Venous blood

127

564

2.30

16.76

2.3

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

425

2792

1.60

16.67

2.0

1.7

—

(3016038) Potassium [Moles/volume] in Urine

171

3.44

16.57

1.4

1.2

mmol/l

32.0

34.5

0.37

149

(21494755) Public health laboratory ask at order entry panel

1352

0.27

16.21

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.29

16.07

1.1

—

(36304419) Bacteria [Presence] in Urine

884

6791

1.41

16.05

4.4

3.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1171

9439

1.37

15.93

3.3

2.8

ug/l

151.5

160.0

0.55

1026

8557

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.63

15.69

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

459

3111

1.55

15.68

2.8

3.8

u/l

254.8

248.6

0.24

424

2907

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.37

15.67

4.4

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.37

15.67

4.4

2.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

256

2.89

15.64

3.3

2.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.51

15.24

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

269

1614

1.73

14.95

2.5

2.6

g/l

9.8

10.7

1.56

232

1463

(3024891) Influenza virus A+B Ag [Presence] in Specimen

133

634

2.14

14.80

1.5

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

133

637

2.13

14.62

2.2

2.3

85.9

88.6

0.60

128

609

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

481

6710

0.67

14.55

2.6

3.1

ug/l

0.8

0.15

326

4605

(3006653) Thiamine [Moles/volume] in Blood

110

3.85

14.30

1.4

1.2

nmol/l

137.3

140.2

0.12

110

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

8.61

14.13

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

657

4890

1.43

13.97

1.9

1.7

mg/l

1.7

1.4

1.06

542

3775

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

4.39

13.79

1.2

1.1

ng/l

67.7

264.7

0.68

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

737

9422

0.72

13.46

3.6

4.5

20.6

22.2

1.98

334

4791

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1097

8936

1.34

13.34

2.5

2.2

nmol/l

74.5

77.0

1.78

925

7814

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

941

0.22

13.19

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

157

3.22

13.00

2.0

16.4

—

(3023520) Reticulocytes [#/volume] in Blood

369

2486

1.55

12.84

2.4

2.5

e9/l

71.6

67.3

1.48

293

1922

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

229

1375

1.72

12.69

1.6

1.7

g/l

1.8

1.5

3.31

189

1158

(3028026) IgM [Mass/volume] in Serum or Plasma

214

1265

1.74

12.55

1.5

1.9

g/l

1.2

1.4

0.73

184

1147

(3019225) pH of Specimen

367

2482

1.54

12.54

5.3

4.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.22

11.98

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

171

3.01

11.90

2.0

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

342

2308

1.54

11.79

2.1

2.4

g/l

64.9

66.1

1.36

302

2083

(3033705) Calcium.ionized [Moles/volume] in Venous blood

398

2.27

11.65

3.0

2.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

306

2034

1.56

11.28

1.8

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

4.51

10.94

2.4

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

115

583

2.01

10.94

2.3

2.5

233.3

197.8

2.78

108

557

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

100

483

2.10

10.84

1.5

1.6

—

(40757373) Influenza virus identified in Isolate

4.31

10.76

1.9

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.79

10.74

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.79

10.74

1.5

2.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

150

3.03

10.64

3.4

3.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

707

5546

1.35

10.63

1.9

1.7

pmol/l

26998692.5

19681621.1

0.15

563

4517

(3028433) Virus identified in Specimen by Culture

4.18

10.34

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

107

3.39

10.26

2.6

2.1

umol/l

60.1

53.4

0.52

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.57

10.19

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.69

10.18

1.1

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

280

1869

1.54

10.13

3.9

ng/l

94.6

98.6

0.27

227

1591

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1968

21532

0.78

10.02

4.9

4.8

mmol/l

6.3

6.1

4.41

1705

19226

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1879

20662

0.79

9.92

7.0

6.2

mmol/mol

42.3

40.8

6.16

1663

18859

(3000494) Fungus identified in Specimen by Culture

361

2554

1.46

9.86

1.7

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

298

2033

1.51

9.74

5.9

4.0

mmol/l

1.2

2.94

273

1765

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

330

2300

1.48

9.72

1.8

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

288

2.35

9.67

1.2

1.6

g/l

0.7

0.9

0.93

225

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.59

9.64

1.5

2.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

447

2.07

9.48

4.2

3.8

61.8

58.7

1.23

447

(3025941) Bacteria identified in Stool by Culture

185

1137

1.66

9.44

1.4

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

130

3.02

9.26

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

755

6086

1.31

9.24

1.8

1.6

nmol/l

19.3

19.5

0.15

648

5186

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

164

2.77

9.12

1.4

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

357

2563

1.44

9.01

3.8

3.1

ng/l

282.7

275.0

0.10

321

2342

(3051611) Lipemic interference index of Serum or Plasma

248

2.40

8.97

4.6

3.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.67

8.82

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

202

1295

1.60

8.72

1.6

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

328

2.19

8.69

1.6

1.7

ug/l

15.8

26.3

1.78

321

(3000570) Elastase.pancreatic [Mass/mass] in Stool

117

648

1.84

8.62

1.4

1.5

ug/g

229.0

273.8

1.69

396

(3030905) Polymorphonuclear cells [#/volume] in Blood

430

2.03

8.58

3.9

3.5

e9/l

5.0

4.4

1.17

430

(3013512) EKG study

872

7226

1.28

8.55

5.5

4.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.39

8.52

2.3

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

331

2.17

8.50

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.49

1.4

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.49

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.49

1.4

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

126

2.96

8.49

1.4

1.8

—

(3017569) Oxygen content in Arterial blood

137

2.87

8.48

2.1

2.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.79

8.32

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

2.69

8.31

2.0

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1012

11800

0.79

8.26

4.2

5.1

ug/l

3.5

4.0

0.46

838

10463

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

162

2.68

8.22

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

631

5039

1.31

8.15

5.6

4.2

kg/l

1.0

0.07

100

785

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

137

813

1.72

8.01

1.8

1.5

titre

144.0

167.2

—

(3023410) Appearance of Cerebral spinal fluid

206

2.45

7.98

1.5

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.18

7.92

2.1

umol/l

20.4

14.6

1.08

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

148

2.72

7.92

1.5

1.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

318

2.13

7.71

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

524

4108

1.33

7.69

3.8

3.2

e6/l

2.5

1.6

1.67

322

2371

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

427

1.97

7.68

7.9

5.5

iu/ml

202.4

657.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

112

637

1.79

7.61

4.8

3.3

mg/l

1.8

1.7

0.39

565

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

129

2.81

7.58

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

100

550

1.84

7.58

1.1

1.2

titre

81.5

88.6

0.11

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.35

7.55

1.0

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

334

2.09

7.55

3.1

2.8

u/ml

88514.7

2413.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

514

0.21

7.52

1.5

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

3.81

7.52

4.4

3.0

ml/dl

13.6

15.0

1.39

(40768797) Stomach Pathology biopsy report

393

2969

1.37

7.35

1.4

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

172

2.52

7.33

1.3

1.2

g/l

2.7

2.9

0.22

125

(3024139) IgG subclass 3 [Mass/volume] in Serum

172

2.52

7.33

1.3

1.2

g/l

0.4

0.29

123

(3027135) IgG subclass 1 [Mass/volume] in Serum

172

2.52

7.33

1.3

1.2

g/l

6.6

7.0

0.27

124

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1314

0.51

7.30

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

487

1.87

7.20

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

215

1466

1.50

7.08

5.2

3.2

e9/l

5.0

4.2

2.07

136

1071

(3004809) Band form neutrophils/100 leukocytes in Blood

433

1.92

7.07

2.8

3.9

1.8

1.5

0.29

329

(40761536) Microorganisms panel - Urine sediment

275

1968

1.43

7.07

5.5

4.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

423

5411

0.75

6.98

1.7

1.6

mmol/l

1.5

1.4

1.51

370

4497

(4015189)

3.45

6.83

1.8

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

348

2609

1.37

6.83

3.2

3.9

ug/l

5.3

24.9

4.21

292

2182

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

133

2.65

6.64

2.2

2.4

12.5

14.6

0.33

(3017181) Myelocytes/100 leukocytes in Blood

269

1941

1.42

6.61

3.9

4.1

1.0

0.9

0.05

116

606

(3027456) Digoxin [Moles/volume] in Serum or Plasma

115

693

1.68

6.42

3.7

3.1

nmol/l

0.8

0.27

519

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

14.32

6.39

1.3

1.0

mmol/l

—

(3003434) Protein [Mass/volume] in Pleural fluid

472

1.82

6.31

1.5

g/l

28.1

30.4

0.80

417

(4062490)

173

2.39

6.29

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

215

1503

1.46

6.28

3.9

3.0

e6/l

0.3

0.24

215

1469

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

114

2.74

6.27

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

115

699

1.67

6.23

1.4

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

109

2.77

6.21

1.1

3.4

mg/l

73.4

64.5

0.31

(40768806) Pleura Pathology biopsy report

353

1.95

6.21

1.5

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

535

1.76

6.15

1.4

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.53

5.98

1.0

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

334

2541

1.35

5.97

1.3

titre

391.5

471.9

0.49

531

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

190

2.28

5.96

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

101

2.79

5.89

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.40

5.86

9.0

7.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.30

5.85

2.0

1.9

—

(3011412) CD3 cells [#/volume] in Blood

186

2.27

5.80

2.1

2.4

e9/l

1.4

1.1

0.88

106

(4094501)

585

0.35

5.77

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

114

2.65

5.73

1.4

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

3.25

5.72

1.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

2.73

5.69

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

322

1.94

5.68

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.84

5.67

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

288

2.00

5.65

2.3

4.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

139

2.46

5.61

1.5

3.4

—

(3012441) Differential panel - Pleural fluid

362

1.87

5.47

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

459

3695

1.28

5.46

1.6

1.5

g/l

2.9

2.7

0.88

272

2201

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.96

5.44

2.4

—

(3037756) Immunofixation for Serum or Plasma

101

617

1.66

5.41

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

279

1.99

5.41

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

280

1.98

5.36

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

280

1.98

5.36

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.35

5.29

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

646

0.41

5.29

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.86

5.26

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

135

1997

0.66

5.23

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

224

2.07

5.07

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

178

2.21

5.06

1.1

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

257

1928

1.36

5.05

1.7

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

560

1.66

5.03

1.4

g/l

0.2

0.12

534

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

205

2.11

5.01

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

704

6010

1.22

4.93

4.8

3.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

296

1.91

4.92

4.1

3.5

—

(3029937) Albumin [Presence] in Urine by Test strip

722

6182

1.22

4.91

5.5

4.1

estimate

0.0

1.28

243

1981

(3002179) Metamyelocytes/100 leukocytes in Blood

234

1739

1.37

4.89

3.8

4.0

1.1

0.6

1.12

428

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

519

4296

1.25

4.87

3.5

2.9

e6/l

1.2

1.1

0.31

319

2544

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

153

1056

1.47

4.84

2.8

3.2

pmol/l

4.2

4.4

1.97

130

908

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

563

4709

1.24

4.80

3.8

3.0

mmol/l

2.5

2.88

449

4067

(3021440) Promyelocytes/100 leukocytes in Blood

244

1832

1.36

4.78

4.0

4.2

0.1

0.43

105

557

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

285

1.91

4.78

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

2.23

4.68

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.12

4.63

2.7

2.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1252

11306

1.17

4.63

5.1

3.8

estimate

0.0

0.80

271

2055

(3001893) Eosinophils/100 leukocytes in Pleural fluid

115

2.45

4.62

1.7

1.5

3.0

2.2

0.19

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

981

8683

1.19

4.61

5.6

4.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.22

4.61

1.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

282

1.89

4.59

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

8.20

4.56

1.0

—

(3044889) 12 lead EKG panel

1478

16039

0.86

4.54

5.0

4.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.73

4.51

2.5

1.8

ug/l

71.2

58.5

0.36

(3024522) Salmonella sp identified in Specimen by Organism specific culture

284

1.88

4.50

1.4

—

(3025159) Blasts/100 leukocytes in Blood

226

1695

1.36

4.48

4.1

4.2

0.0

0.4

1.12

455

(40760892) CBC W Ordered Manual Differential panel - Blood

559

4710

1.23

4.43

5.8

4.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.01

4.39

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1234

11166

1.17

4.38

5.0

3.8

estimate

0.0

0.00

279

2113

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.56

4.38

1.3

ug/l

5.5

109.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

116

774

1.52

4.35

5.6

4.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

577

1.59

4.28

1.5

1.4

g/l

1.2

0.27

547

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

261

1.89

4.26

1.8

2.0

u/field

1.1

1.8

1.15

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.36

4.08

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.36

4.08

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.36

4.08

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1227

11143

1.16

4.08

6.8

5.1

estimate

0.0

0.50

282

2134

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

168

2.10

4.07

1.1

1.2

titre

54.3

133.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

106

705

1.52

4.06

2.0

3.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

114

1654

0.68

4.06

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

317

1.78

4.03

1.5

1.4

u/l

265.8

317.6

0.58

301

(3050129) First trimester maternal screen panel - Serum or Plasma

210

0.24

3.95

1.2

1.4

—

(3021589) Normoblasts [#/volume] in Blood

1095

9881

1.16

3.93

17.4

9.9

e9/l

0.0

0.15

878

8041

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

380

1.70

3.92

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.27

3.90

1.1

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

3.27

3.90

2.0

e6/l

488.9

300.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

138

2.18

3.89

1.6

1.5

61.3

66.6

0.29

109

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

2.17

3.82

1.7

2.0

—

(3007463) Buprenorphine [Presence] in Urine

12.02

3.76

1.2

5.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

924

1.42

3.60

1.9

3.0

mg/l

42.2

67.0

0.85

740

(3014765) Yersinia sp identified in Stool by Organism specific culture

628

1.51

3.57

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

265

1.78

3.48

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

624

1.50

3.47

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.62

3.47

2.6

2.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

472

1.58

3.46

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

634

1.50

3.43

1.3

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

925

1.41

3.42

1.9

3.0

mg/l

84.2

68.0

0.30

737

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1972

20753

0.87

3.42

28.9

15.7

ml/min/173m2

79.8

75.0

12.70

1658

17202

(40768800) Prostate Pathology biopsy report

710

0.56

3.42

1.1

1.2

—

(4035726)

236

1856

1.29

3.42

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

126

2.15

3.41

1.2

1.3

nmol/l

1.0

1.1

0.17

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

126

901

1.41

3.40

1.9

3.0

ratio

46.1

1.9

0.46

(3051387) C reactive protein [Mass/volume] in Capillary blood

604

1.50

3.37

4.1

3.6

mg/l

33.2

30.0

0.33

394

(3003338) MCHC [Mass/volume]

1738

18432

0.88

3.36

43.1

21.4

g/l

329.8

332.3

20.12

1693

18169

(3000963) Hemoglobin [Mass/volume] in Blood

2377

24684

0.86

3.35

49.1

24.2

g/l

125.7

134.3

107.68

2307

24159

(3007461) Platelets [#/volume] in Blood

2376

24671

0.86

3.33

48.7

24.0

e9/l

248.2

238.5

8.35

2297

23873

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.45

3.33

1.1

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

2377

24680

0.86

3.33

48.6

24.0

e12/l

4.2

4.4

71.83

2278

23796

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.72

3.32

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

247

1.79

3.32

1.8

1.5

—

(3024731) MCV [Entitic volume]

2377

24678

0.87

3.31

48.5

23.9

91.4

91.5

0.54

2314

24146

(3035941) MCH [Entitic mass]

2377

24678

0.87

3.31

48.4

23.9

30.1

30.4

9.88

2314

24146

(4027681)

108

2.23

3.31

1.3

1.2

—

(3010813) Leukocytes [#/volume] in Blood

2378

24686

0.87

3.30

48.7

24.0

e9/l

7.8

7.0

43.17

2282

23793

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

510

1.54

3.30

3.6

3.3

u/ml

159.0

1126.4

1.08

468

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

2.12

3.29

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

116

2.16

3.22

1.2

1.3

u/l

211.1

427.8

1.13

107

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.34

3.19

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

238

2968

0.79

3.19

1.2

u/ml

14.7

12.4

0.16

1105

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

144

2.02

3.15

1.2

1.1

mg/l

112.3

45.0

0.41

120

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

151

2.00

3.14

1.5

2.1

e6/l

411.0

696.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.96

3.13

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.51

3.11

1.0

1.1

—

(40768804) Tissue Pathology biopsy report

775

8641

0.86

3.11

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2275

23658

0.87

3.10

15.4

10.5

u/l

27.6

26.5

0.79

2181

22628

(3013727) Leukocytes other/100 leukocytes in Blood

2.29

3.10

2.1

3.8

57.8

54.8

0.22

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

181

1.89

3.05

1.1

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

416

1.57

3.04

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.59

3.04

1.8

1.3

nmol/l

122.1

129.1

0.04

(3002619) Bacteria identified in Specimen by Culture

2.90

3.02

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

161

1.93

2.99

1.6

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

324

1.65

2.99

1.3

1.4

mmol/l

6.8

6.6

0.17

303

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.01

2.97

7.8

8.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

190

1.85

2.96

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

121

2.07

2.92

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

121

2.07

2.92

1.1

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.32

2.91

1.2

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.34

2.90

1.1

1.0

—

(4306422)

258

1.72

2.90

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

135

2.01

2.90

1.6

2.3

e6/l

489.7

562.7

0.30

117

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

135

2.01

2.90

2.2

2.7

37.8

36.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

2.14

2.90

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

170

1.89

2.90

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

382

1.58

2.89

1.5

1.4

e6/l

83468.5

66672.3

0.12

232

(3023199) Leukocytes [#/volume] in Pleural fluid

422

1.55

2.88

1.4

1.5

e6/l

1167.0

1893.5

1.35

304

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.59

2.87

1.7

1.6

6.0

4.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

384

1.57

2.83

3.4

3.5

—

(40761535) Cells panel - Urine sediment

261

2132

1.24

2.80

4.6

3.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.65

2.79

6.9

7.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

217

1.76

2.76

1.1

u/l

55.4

54.2

0.05

144

(3012516) Albumin [Mass/volume] in Urine

644

7220

0.87

2.75

3.2

mg/l

682.1

278.3

0.96

423

4768

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.72

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.01

2.72

9.7

2.6

mg/l

2.2

2.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

349

1.59

2.70

1.1

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

139

1.95

2.69

2.6

2.1

umol/l

8.7

28.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

323

0.43

2.67

1.1

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

154

1.89

2.65

1.8

2.0

nmol/l

17.6

18.3

0.14

143

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

393

1.54

2.59

1.3

miu/ml

218.5

220.7

0.01

149

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

458

1.50

2.58

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

690

7667

0.87

2.58

3.9

4.0

mg/mmol

13.2

9.9

0.99

465

5007

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.90

2.58

1.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

283

1.63

2.57

1.1

1.2

u/ml

4.4

5.3

0.14

138

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

7.15

2.55

1.2

1.1

nmol/l

307.0

228.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.46

2.54

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

165

0.30

2.54

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

165

0.30

2.54

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

165

0.30

2.54

1.2

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

137

1.91

2.45

1.2

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

295

1.60

2.45

1.1

g/l

1.7

1.6

1.32

270

(3017354) Segmented neutrophils/100 leukocytes in Blood

264

1.64

2.44

2.7

3.9

64.7

56.7

1.45

167

(3008898) HLA-B27 [Presence]

531

0.58

2.42

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

176

0.34

2.39

1.2

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

146

1.86

2.37

1.7

1.6

u/field

1.2

3.6

1.12

105

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

324

1.55

2.30

1.0

1.1

iu/ml

1.4

75.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

546

1.42

2.28

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.48

2.27

1.0

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2337

22599

1.12

2.25

37.8

16.6

mg/l

36.4

27.5

30.49

2186

18465

(3021788) Differential panel - Synovial fluid

423

1.47

2.25

1.6

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.28

2.24

1.1

1.4

g/l

11.6

13.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

473

1.45

2.24

1.9

1.7

nmol/l

0.9

0.8

0.44

392

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

120

918

1.32

2.23

3.1

3.0

u/ml

275.1

5587.6

1.05

103

780

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

369

1.50

2.17

1.6

1.4

u/ml

101.6

119.3

0.52

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

394

1.48

2.16

1.2

—

(3022621) pH of Urine by Test strip

199

1631

1.23

2.14

3.1

3.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

166

1334

1.26

2.12

2.6

2.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1009

1.29

2.06

1.6

2.2

g/l

10.3

10.4

0.07

849

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

215

1.63

2.03

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

585

5272

1.13

2.01

4.7

3.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.08

2.01

1.0

1.2

—

(3037121) Protein [Mass/volume] in Urine

117

907

1.30

2.01

3.2

3.1

g/l

0.2

0.3

0.83

386

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.01

2.00

2.9

2.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2301

23705

0.90

1.99

36.2

19.4

umol/l

82.8

86.0

2.59

2295

23693

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

344

1.49

1.99

1.7

2.1

31.5

32.6

0.81

339

(3033799) Differential panel - Peritoneal fluid

2.15

1.98

1.3

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.96

1.0

2.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.55

1.94

6.4

8.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

457

4066

1.14

1.91

1.3

1.2

u/ml

0.9

1.7

2.71

108

1054

(3043238) Trisomy 21 risk [Likelihood] in Fetus

140

0.36

1.88

1.2

1.5

—

(3035880) pH of Pleural fluid

197

1.63

1.86

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.65

1.86

1.0

2.1

—

(3042733) HLA Ab [Presence] in Serum

2.21

1.84

3.4

5.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.17

1.82

1.0

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

224

2637

0.84

1.80

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.05

1.80

1.6

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

288

1.50

1.77

1.1

1.2

u/ml

1.5

3.5

1.10

101

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

670

1.32

1.75

2.3

ug/min

115.4

97.2

0.21

397

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

153

0.39

1.75

1.3

1.5

—

(3005033) Fetal Nuchal fold Thickness US

136

0.37

1.75

1.2

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

137

0.36

1.74

2.2

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

265

1.52

1.73

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

155

1.68

1.72

1.0

ng/l

291.9

301.4

0.08

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.14

1.71

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.96

1.69

1.3

2.4

e6/l

1881.0

810.0

0.28

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1068

1.25

1.66

1.7

2.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.89

1.65

1.1

1.2

ratio

1.3

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.80

1.65

5.1

5.8

ug/min

60.3

65.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1069

1.24

1.64

1.7

2.2

g/l

7.5

7.4

0.16

784

(3013707) Erythrocyte sedimentation rate by Westergren method

1740

16712

1.09

1.64

4.8

4.0

mm/h

18.6

13.7

21.37

1590

15271

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.98

1.64

1.2

1.4

24.1

23.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

103

1299

0.79

1.63

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.25

1.63

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

369

1.42

1.62

1.3

1.2

u/ml

288.8

273.9

0.12

218

(3045788) Cell count panel - Pleural fluid

336

1.43

1.61

1.6

1.4

—

(3044007) Cell count panel - Peritoneal fluid

2.07

1.59

1.3

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

1066

1.24

1.57

1.7

2.2

g/l

3.7

3.8

0.34

753

(3017446) Testosterone [Moles/volume] in Serum or Plasma

175

2077

0.83

1.57

2.5

2.2

nmol/l

12.5

0.00

147

1809

(36660697) Celiac disease serology panel - Serum

171

1431

1.21

1.57

1.1

—

(1002224) Polysomnography panel

682

0.71

1.56

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

104

826

1.27

1.55

1.3

2.1

g/l

36.8

37.1

0.14

697

(3043410) Blood group antigens tested for on Red Blood Cells

1.89

1.54

1.8

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

272

3106

0.86

1.53

1.2

iu/ml

32.6

33.9

0.07

990

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

980

1.24

1.53

1.5

2.2

g/l

3.3

3.1

1.90

773

(3044941) Cell count panel - Synovial fluid

384

1.39

1.49

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

617

0.71

1.48

1.7

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.37

1.45

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.88

1.44

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.92

1.43

1.3

2.1

e6/l

51169.7

27975.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.73

1.43

1.5

1.2

—

(40768441) Liver Pathology biopsy report

149

1.62

1.41

2.1

1.3

—

(3000330) Specific gravity of Urine by Test strip

159

1338

1.20

1.40

5.0

3.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

157

1.60

1.40

1.0

ng/l

757.2

612.3

0.95

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

157

1.60

1.40

1.0

ng/l

44.5

43.9

0.02

(3004716) Salmonella sp identified in Stool by Organism specific culture

110

892

1.24

1.40

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.42

1.39

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.42

1.39

4.3

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

150

1.60

1.37

2.9

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.94

1.36

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.94

1.36

1.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

636

1.28

1.35

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

725

1.26

1.35

1.4

2.2

g/l

0.0

0.00

663

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

735

1.26

1.34

1.3

2.2

g/l

0.0

0.00

665

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.15

1.33

1.6

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

109

889

1.23

1.33

1.5

2.3

g/l

0.5

1.2

1.70

753

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

1.62

1.32

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.89

1.28

4.1

3.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

186

1.51

1.26

1.1

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

778

1.24

1.25

1.4

2.2

g/l

0.0

1.62

705

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

337

1.37

1.25

1.6

2.1

mg/l

37.1

24.1

0.56

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

592

1.27

1.23

1.7

1.6

—

(44806071)

2.63

1.21

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

196

1.48

1.21

2.2

2.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.31

1.18

1.2

—

744.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

149

1.55

1.17

1.3

1.2

mmol/l

12.4

11.8

0.11

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

1.15

0.0

1.7

—

153.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

130

1102

1.19

1.11

1.4

1.3

u/ml

177.2

249.2

0.99

111

1012

(3045462) Protein/Creatinine [Ratio] in Urine

2.38

1.09

9.2

4.0

g/mol

13.1

23.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

311

2813

1.12

1.07

4.1

4.6

32.7

0.01

228

1832

(4281824)

169

1.48

1.07

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

236

1.40

1.06

1.7

1.3

nmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.93

1.06

2.9

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

245

1.39

1.05

1.7

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

642

1.24

1.05

1.5

1.6

iu/ml

0.0

17.7

0.88

139

(3000475) Leukocytes [#/volume] in Synovial fluid

570

1.25

1.05

1.5

1.6

e6/l

19415.9

17779.2

0.10

402

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.06

1.03

4.3

5.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.06

1.03

2.6

2.4

u/field

0.1

0.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.92

1.02

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

0.47

1.01

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

458

1.27

0.99

1.4

1.5

—

(40768443) Skin Pathology biopsy report

981

0.82

0.99

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

459

1.27

0.98

1.6

1.2

u/l

21.4

48.2

2.65

398

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.97

0.0

1.3

—

(3002256) Pathology report gross observation

270

2983

0.90

0.97

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

100

1.60

0.96

1.1

1.0

u/l

1.1

0.12

(3020876) Protein [Mass/time] in 24 hour Urine

224

1.39

0.96

1.6

1.9

—

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

149

1.48

0.95

1.9

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

259

1.36

0.95

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.77

0.94

1.2

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.89

0.94

1.1

g/l

14.4

16.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

679

1.21

0.93

1.3

1.2

u/ml

0.3

0.7

—

(3000012) Reticulocyte production index

142

1.48

0.92

2.0

1.5

—

(3011648) Oxygen content in Venous blood

193

1.40

0.90

1.4

2.4

11.7

10.9

0.33

193

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

105

895

1.18

0.89

2.0

1.9

u/l

39.8

38.1

0.32

775

(40768793) Breast Pathology biopsy report

300

0.70

0.87

1.6

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

136

1.47

0.86

1.6

1.5

u/l

1.4

7.7

2.62

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

343

1.29

0.86

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

317

1.30

0.85

2.7

2.5

u/ml

800.6

200.1

0.35

306

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.67

0.85

2.3

2.4

ug/l

26.6

133.4

0.46

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.94

0.84

1.0

1.1

—

(3036603) Volume of Urine

137

1.46

0.84

1.5

1.6

1912.3

1730.0

—

(3020491) Glucose [Moles/volume] in Blood

179

1.40

0.84

3.0

2.7

mmol/l

8.8

6.9

0.79

113

(3032773) Endomysium IgG Ab [Titer] in Serum

154

1.43

0.83

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

296

0.71

0.82

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

330

0.73

0.81

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

2270

23089

0.94

0.79

34.1

15.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1239

11979

1.06

0.79

3.3

2.6

—

(3024932) HLA-DR beta [Type]

1.73

0.79

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.67

0.78

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

348

1.27

0.78

1.9

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

484

1.22

0.77

1.3

1.4

u/l

11.3

8.1

0.65

395

(3000492) Spirometry study

168

1875

0.89

0.76

1.8

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

270

1.30

0.76

1.9

2.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.60

0.74

1.2

1.1

miu/ml

1287.1

1580.4

0.53

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1956

19955

0.95

0.74

5.0

4.4

mu/l

2.0

2.1

0.82

1713

17873

(3021387) Prolactin [Units/volume] in Serum or Plasma

478

1.22

0.73

1.8

1.6

mu/l

410.9

292.1

0.87

444

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

134

1185

1.14

0.73

2.3

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

133

0.60

0.73

1.8

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

134

0.60

0.73

1.8

1.1

—

(3024471) HLA-A [Type]

1.67

0.72

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

255

1.30

0.71

1.7

1.4

—

(3045142) Bone marrow Pathology biopsy report

264

1.29

0.71

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

238

1.31

0.70

1.4

1.3

pmol/l

362.0

281.1

0.36

186

(3006270) Folate [Moles/volume] in Blood

247

1.30

0.70

1.4

1.2

nmol/l

318.9

330.8

0.13

199

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

565

1.19

0.68

1.9

2.0

mg/l

12.1

12.6

0.18

514

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.85

0.68

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.53

0.68

1.1

1.0

—

(4034850)

742

1.16

0.68

19.8

11.6

—

(3000285) Sodium [Moles/volume] in Blood

1.63

0.66

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

145

1299

1.12

0.66

2.4

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.59

0.65

1.4

1.1

pmol/l

—

6.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.61

0.65

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

103

1.46

0.65

3.5

3.4

—

(3000034) Microalbumin [Mass/volume] in Urine

225

1.29

0.63

4.3

3.2

mg/l

79.8

41.4

0.57

171

(3047007) Chlamydophila sp Ab [Presence] in Serum

243

1.28

0.62

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

1.63

0.62

1.4

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

586

0.83

0.60

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

299

1.24

0.59

2.8

2.3

u/l

5681.6

2820.9

0.28

110

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.58

0.0

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.51

0.58

1.0

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

140

1.36

0.58

1.4

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

106

1.42

0.57

1.9

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.48

0.57

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

158

1.33

0.57

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

0.57

0.56

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1777

18095

0.96

0.55

40.9

19.8

14.5

13.9

45.60

1724

17592

(3010726) Horse dander IgE Ab [Units/volume] in Serum

205

0.73

0.54

1.1

u/ml

0.7

2.9

—

(3004775) Volume in Urine collected for unspecified duration

213

1.27

0.54

2.6

2.2

535.2

618.0

0.61

125

(3019832) Treponema pallidum Ab [Presence] in Serum

120

1081

1.11

0.53

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

116

1043

1.12

0.53

1.2

iu/ml

165.7

140.3

0.19

376

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.48

0.53

1.2

1.1

102.4

99.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.46

0.50

1.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

308

1.20

0.48

1.3

1.1

—

(4024509)

217

1.25

0.48

1.8

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.49

0.47

1.1

1.3

—

139.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

744

1.12

0.43

1.1

—

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

104

1.35

0.43

1.0

—

(4211845)

113

1.33

0.42

3.5

3.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

625

6465

0.96

0.42

3.1

2.9

umol/l

2116.2

6628.1

3.66

527

5518

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

251

0.80

0.42

1.1

u/ml

0.3

2.3

2.60

112

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.56

0.42

11.8

8.9

mmol/l

5.4

6.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3024316) Viscosity of Plasma

0.00

0.41

0.0

1.3

—

1.5

—

(3025315) Body weight

0.00

0.40

0.0

2.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

4.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.4

—

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

101

0.69

0.39

1.0

—

(3014891) Appearance of Pleural fluid

1.31

0.39

1.8

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.39

0.0

2.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(3024263) Appearance of Synovial fluid

142

1.27

0.38

1.3

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.38

0.38

1.4

1.8

nmol/l

1.5

10.1

0.82

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.39

0.38

1.4

umol/l

56.0

51.6

—

(3003694) ABO and Rh group [Type] in Blood

588

5691

1.04

0.38

1.4

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

223

0.81

0.35

1.1

u/ml

0.7

1.7

—

106

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

222

0.81

0.34

1.1

u/ml

2.9

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

508

0.88

0.32

1.3

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.28

0.32

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.28

0.32

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.28

0.32

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.28

0.32

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.35

0.32

1.1

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

252

0.83

0.32

1.5

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

252

0.83

0.32

1.5

1.1

—

(3049717) Cytology report of Urine Cyto stain

134

1255

1.07

0.31

2.6

2.8

—

(3051101) Glucose [Moles/volume] in Cord blood

1.35

0.31

5.9

5.7

—

(3017704) Immunofixation for Urine

165

1.21

0.31

1.3

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.72

0.30

1.0

1.5

ug/l

4.8

10.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

485

1.12

0.30

1.4

1.2

u/ml

2.3

3.8

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.23

0.29

1.3

1.2

115.6

108.6

—

(44806420)

103

1.26

0.28

1.8

2.5

—

(3048689) Calprotectin [Mass/mass] in Stool

229

2190

1.05

0.28

2.2

2.3

ug/g

262.9

162.1

1.57

179

1720

(3004451) EKG impression Narrative

149

1.21

0.27

1.6

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

271

1.15

0.27

1.1

—

10.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

490

1.10

0.27

1.4

1.2

u/ml

12.8

5.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.21

0.26

1.4

2.4

—

(3004616) Nuclear Ab [Presence] in Serum

262

1.15

0.26

1.3

1.2

—

(44813793)

104

1.25

0.26

1.1

1.0

—

(4010399)

162

1541

1.05

0.25

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

170

0.82

0.25

1.1

u/ml

1.2

2.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

435

1.10

0.25

1.4

1.8

iu/l

2.8

4.8

1.11

139

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.28

0.24

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

274

1.13

0.24

1.7

1.5

66.4

64.3

0.09

176

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.71

0.24

1.7

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

399

1.10

0.23

1.5

1.2

u/ml

1.4

5.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2361

23460

1.02

0.23

41.4

19.7

mmol/l

139.0

139.6

15.40

2283

22759

(40759836) Histone Ab [Presence] in Serum by Immunoblot

134

1.19

0.22

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.19

0.22

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.19

0.22

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.77

0.22

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

191

1.15

0.21

1.0

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

180

1876

0.96

0.21

3.3

2.8

ml/min/173m2

60.4

62.0

0.18

805

(3009542) Hematocrit [Volume Fraction] of Blood

1982

19973

0.98

0.21

35.2

17.6

36.4

39.2

19.29

1132

13058

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

167.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

230

0.87

0.21

1.1

u/ml

5.8

0.00

124

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

830

1.06

0.20

1.1

1.0

—

(3022145) Colonoscopy Study observation

229

2367

0.97

0.19

1.4

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.17

0.18

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.17

0.18

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.17

0.18

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

560

0.93

0.18

2.4

1.9

—

(4268621)

194

1.13

0.18

1.9

2.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

446

0.92

0.18

2.1

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.17

0.17

2.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.16

0.16

1.1

2.4

ug/l

0.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

225

1.11

0.16

1.4

1.3

e6/l

45249.2

131879.9

0.88

157

(3037556) Urate [Mass/volume] in Serum or Plasma

0.79

0.15

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.75

0.15

4.2

2.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.75

0.15

1.5

1.2

75.6

63.5

—

(3009508) Creatinine [Moles/volume] in Urine

760

7503

1.02

0.14

3.8

3.2

mmol/l

6.9

7.6

4.94

600

6184

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

246

1.10

0.14

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2361

23511

1.02

0.14

40.8

19.9

mmol/l

4.0

7.87

2282

22774

(40768446) Kidney Pathology biopsy report

1.19

0.14

1.5

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

0.80

0.13

5.0

6.5

—

(21494434) Karyotype in Bone marrow

247

1.09

0.13

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

979

0.96

0.13

1.7

1.9

—

(3025130) Human papilloma virus identified in Specimen

110

0.82

0.13

1.3

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

1.13

0.12

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

1.13

0.12

1.2

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

239

1.09

0.12

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

376

1.06

0.11

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

312

3066

1.02

0.11

14.2

8.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

681

1.04

0.11

1.6

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.14

0.10

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.11

0.09

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

361

0.94

0.09

1.6

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.09

0.09

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.06

0.09

1.4

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.08

0.08

1.4

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

826

1.03

0.07

1.1

titre

—

191.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.07

0.07

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

276

0.94

0.07

1.2

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

143

0.91

0.07

1.1

u/ml

0.6

0.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.07

0.07

1.0

1.2

—

0.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.11

0.06

1.9

1.4

4.5

4.2

—

(3014051) Protein [Presence] in Urine by Test strip

528

0.97

0.06

1.9

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

211

0.95

0.04

2.0

1.4

24.4

25.3

0.04

130

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1604

16076

1.00

0.04

4.1

3.6

pmol/l

14.9

15.0

0.86

1396

14326

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

349

1.03

0.03

1.4

1.1

u/ml

63.5

56.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

141

1.06

0.03

1.7

1.5

nmol/l

0.5

0.3

—

114

(4146454)

276

0.98

0.00

2.1

2.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

674

1.01

0.00

1.9

1.8

nmol/l

46.3

40.7

1.03

648

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

135

1.04

0.00

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

131

0.99

0.00

1.4

1.5

—

(3025577) Chromium [Mass/volume] in Blood

151

0.99

0.00

1.9

2.1

ug/l

4.5

2.0

—

129

(3023430) Cat dander IgE Ab [Units/volume] in Serum

154

0.97

0.00

1.0

1.1

u/ml

1.6

3.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

414

0.99

0.00

1.3

1.4

iu/l

30.7

27.0

0.24

346

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

147

1.02

0.00

1.9

2.1

ug/min

41.7

121.8

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3039528) Macrophages/100 leukocytes in Pleural fluid by Manual count

0.00

0.0

3.8

—

29.8

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1745.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

1.6

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

403.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.7

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.93

0.00

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

2.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.91

0.00

1.3

2.2

—

(3034426) Prothrombin time (PT)

0.92

0.00

1.0

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.90

0.00

1.4

1.8

u/l

40.9

59.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PNEUMONISOLLIQ and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_PNEUMONISOLLIQ	5.008 [4.19, 5.99]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.762

During the follow-up period (1.1.1998 — 31.12.2019), 4625 out of 7739 females with J10_PNEUMONISOLLIQ died.

Males

Parameter	HR [95% CI]	p-value
J10_PNEUMONISOLLIQ	5.458 [4.51, 6.61]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 7664 out of 12966 males with J10_PNEUMONISOLLIQ died.

Mortality risk

Mortality risk for people of age

years, who have J10_PNEUMONISOLLIQ.

N-year risk	Females	Males
1	0.382%	0.948%
5	3.355%	5.324%
10	8.338%	12.43%
15	15.089%	23.066%
20	25.524%	37.068%

Relationships between endpoints

↥

Index endpoint: J10_PNEUMONISOLLIQ – Pneumonitis due to solids and liquids

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pneumonitis due to solids and liquids

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints